GLP-1 News - The Neura Times

H+
Enhancement
Longevity
Technology
Futurism

Terms of Use
About Us

H+
Enhancement
Longevity
Technology
Futurism

Follow

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use

Follow

H+
- Immortality
Human Enhancement
Longevity
Technology
- AI
- Robotics
- Biotechnology
- Nanotechnology
- AR/VR
Futurism
- Futurology
- Space

Terms of Use
About Us

DON’T DIE
AI
Robotics
Nanotech
Biotech
Medicine
Transplantation
Immortality
Cryonics

Home GLP-1

Amylyx Pharmaceuticals Partners with Gubra for GLP-1 Receptor Antagonist Development

Amylyx Pharmaceuticals Partners with Gubra for GLP-1 Receptor Antagonist Development

Biotechnology
Technology

Amylyx Pharmaceuticals Partners with Gubra for GLP-1 Receptor Antagonist Development

January 3, 2025

L’Oréal’s Cell BioPrint: Revolutionary Skin Analysis Tool
Serve Robotics Secures $86M for Last-Mile Delivery Expansion
ElliQ Caregiver Solution: AI Revolutionizing Care for Older Adults
Robotics Investments Surge to $7.4 Billion in October
New Glenn Rocket Prepares for Historic Launch

Aging
Longevity
Digital Immortality
Belarus

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use

© 2025 The Neura Times. All Rights Reserved.

Terms of Use
About Us